131 related articles for article (PubMed ID: 20538797)
1. Long-term follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: an analysis on behalf of Eurocord-EBMT.
Herr AL; Kabbara N; Bonfim CM; Teira P; Locatelli F; Tiedemann K; Lankester A; Jouet JP; Messina C; Bertrand Y; Díaz de Heredia C; Peters C; Chaves W; Nabhan SK; Ionescu I; Gluckman E; Rocha V
Blood; 2010 Sep; 116(11):1849-56. PubMed ID: 20538797
[TBL] [Abstract][Full Text] [Related]
2. [Results of unrelated umbilical cord blood stem cell transplantation for 65 patients in China].
Liao C; Yang X; Xu ZP; Huang YN; Wu SQ; Chen JS; Li Y; Tang XW; Wu JY
Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):220-3. PubMed ID: 16624064
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group.
Locatelli F; Rocha V; Chastang C; Arcese W; Michel G; Abecasis M; Messina C; Ortega J; Badell-Serra I; Plouvier E; Souillet G; Jouet JP; Pasquini R; Ferreira E; Garnier F; Gluckman E
Blood; 1999 Jun; 93(11):3662-71. PubMed ID: 10339472
[TBL] [Abstract][Full Text] [Related]
4. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies.
Kurtzberg J; Prasad VK; Carter SL; Wagner JE; Baxter-Lowe LA; Wall D; Kapoor N; Guinan EC; Feig SA; Wagner EL; Kernan NA;
Blood; 2008 Nov; 112(10):4318-27. PubMed ID: 18723429
[TBL] [Abstract][Full Text] [Related]
5. The impact of anti-HLA antibodies on unrelated cord blood transplantations.
Takanashi M; Atsuta Y; Fujiwara K; Kodo H; Kai S; Sato H; Kohsaki M; Azuma H; Tanaka H; Ogawa A; Nakajima K; Kato S
Blood; 2010 Oct; 116(15):2839-46. PubMed ID: 20628152
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
7. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V; Labopin M; Sanz G; Arcese W; Schwerdtfeger R; Bosi A; Jacobsen N; Ruutu T; de Lima M; Finke J; Frassoni F; Gluckman E; ;
N Engl J Med; 2004 Nov; 351(22):2276-85. PubMed ID: 15564544
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus and methotrexate for the prophylaxis of graft-versus-host disease after unrelated donor cord blood transplantation for adult patients with hematologic malignancies.
Mori T; Aisa Y; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Yamane A; Ikeda Y; Okamoto S
Transplant Proc; 2007 Jun; 39(5):1615-9. PubMed ID: 17580201
[TBL] [Abstract][Full Text] [Related]
9. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
[TBL] [Abstract][Full Text] [Related]
10. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders.
Kwon M; Bautista G; Balsalobre P; Sánchez-Ortega I; Serrano D; Anguita J; Buño I; Fores R; Regidor C; García Marco JA; Vilches C; de Pablo R; Fernández MN; Gayoso J; Duarte R; Díez-Martín JL; Cabrera R
Biol Blood Marrow Transplant; 2014 Dec; 20(12):2015-22. PubMed ID: 25255162
[TBL] [Abstract][Full Text] [Related]
11. Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis.
Cunha R; Loiseau P; Ruggeri A; Sanz G; Michel G; Iori AP; Socié G; Arcese W; Picardi A; Dias de Heredia C; Rio B; Locatelli F; O'Brien TA; Yakoub-Agha I; Angel Diaz M; Milpied N; Bittencourt H; Pedro Souza M; Aljurf M; Charron D; Boudjedir K; Labopin M; Gluckman E; Rocha V
Bone Marrow Transplant; 2014 Jan; 49(1):24-9. PubMed ID: 23955634
[TBL] [Abstract][Full Text] [Related]
12. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
[TBL] [Abstract][Full Text] [Related]
13. Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.
Horwitz ME; Wease S; Blackwell B; Valcarcel D; Frassoni F; Boelens JJ; Nierkens S; Jagasia M; Wagner JE; Kuball J; Koh LP; Majhail NS; Stiff PJ; Hanna R; Hwang WYK; Kurtzberg J; Cilloni D; Freedman LS; Montesinos P; Sanz G
J Clin Oncol; 2019 Feb; 37(5):367-374. PubMed ID: 30523748
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.
Gluckman E; Rocha V; Arcese W; Michel G; Sanz G; Chan KW; Takahashi TA; Ortega J; Filipovich A; Locatelli F; Asano S; Fagioli F; Vowels M; Sirvent A; Laporte JP; Tiedemann K; Amadori S; Abecassis M; Bordigoni P; Diez B; Shaw PJ; Vora A; Caniglia M; Garnier F; Ionescu I; Garcia J; Koegler G; Rebulla P; Chevret S;
Exp Hematol; 2004 Apr; 32(4):397-407. PubMed ID: 15050751
[TBL] [Abstract][Full Text] [Related]
15. Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation.
Baron F; Labopin M; Ruggeri A; Mohty M; Sanz G; Milpied N; Bacigalupo A; Rambaldi A; Bonifazi F; Bosi A; Sierra J; Yakoub-Agha I; Santasusana JM; Gluckman E; Nagler A
J Hematol Oncol; 2015 Oct; 8():107. PubMed ID: 26445106
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
17. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
[TBL] [Abstract][Full Text] [Related]
19. Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.
Mori T; Tanaka M; Kobayashi T; Ohashi K; Fujisawa S; Yokota A; Fujita H; Nakaseko C; Sakura T; Nannya Y; Takahashi S; Kanamori H; Kanda Y; Sakamaki H; Okamoto S;
Biol Blood Marrow Transplant; 2013 Mar; 19(3):486-91. PubMed ID: 23253560
[TBL] [Abstract][Full Text] [Related]
20. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
